Wang Bao-hua, Zhang Guan-nan, Xiao Yi, Wu Bin, Lin Guo-le, Cui Quan-cai, Hu Ke, Zhong Guang-xi, Qiu Hui-zhong
Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.
Zhonghua Wai Ke Za Zhi. 2009 Dec 1;47(23):1779-83.
To study the impact of neoadjuvant therapy on lymph nodes retrieval in locally advanced mid-low rectal carcinoma.
Data collected from 120 patients with locally advanced mid-low rectal cancer (T2-4 and/or N1-2M0) treated from January 2005 to June 2008 was investigated. The patients were divided into two groups: the study group (n=54) was treated with neoadjuvant therapy (preoperative radiation with a total dosage of 50 Gy and synchronous 5-Fu-based chemotherapy) followed by radical tumor resection 4-6 weeks after;the control group (n=66) underwent primary surgery without neoadjuvant therapy. The clinical stage was evaluated before and after neoadjuvant therapy. The total lymph nodes yields, as well as the tumor-positive lymph nodes of each resected specimen was compared between the two groups statistically.
Clinical downstage was achieved in 30 cases (56%) in study group after neoadjuvant therapy. The number of total lymph nodes and positive lymph nodes harvested from each resected specimen in the control group were 14+/-7 and 2.2+/-3.7, meanwhile those were 9+/-6 and 0.7+/-2.4 in study group, which were all significantly lower than those in control group (P<0.01).
Preoperative radiotherapy combined with chemotherapy can downstage the tumor and reduce the retrieval rate of total lymph nodes and positive lymph nodes in locally advanced rectal cancer. It is necessary to retrieve as many lymph nodes as possible for it has some prognostic significance for the patients.
研究新辅助治疗对局部进展期低位直肠癌淋巴结清扫的影响。
调查2005年1月至2008年6月间收治的120例局部进展期低位直肠癌(T2 - 4和/或N1 - 2M0)患者的数据。患者分为两组:研究组(n = 54)接受新辅助治疗(术前放疗总剂量50 Gy并同步进行基于5 - Fu的化疗),4 - 6周后行根治性肿瘤切除术;对照组(n = 66)未接受新辅助治疗直接行一期手术。在新辅助治疗前后评估临床分期。对两组各切除标本的总淋巴结收获量以及肿瘤阳性淋巴结进行统计学比较。
研究组新辅助治疗后30例(56%)患者实现临床降期。对照组各切除标本的总淋巴结数和阳性淋巴结数分别为14±7和2.2±3.7,而研究组分别为9±6和0.7±2.4,均显著低于对照组(P < 0.01)。
术前放疗联合化疗可使肿瘤降期,并降低局部进展期直肠癌的总淋巴结和阳性淋巴结清扫率。尽可能多地清扫淋巴结很有必要,因为这对患者有一定的预后意义。